Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
17th September 2020 | Suma Krishnan | 1,126 | Open or private sale | $47.29 | $53,248.31 |
17th September 2020 | Suma Krishnan | 7,437 | Open or private sale | $46.63 | $346,813.34 |
17th September 2020 | Suma Krishnan | 10,594 | Open or private sale | $46.09 | $488,296.53 |
16th September 2020 | Suma Krishnan | 9,749 | Open or private sale | $46.24 | $450,821.06 |
16th September 2020 | Suma Krishnan | 5,142 | Open or private sale | $46.85 | $240,895.50 |
15th September 2020 | Suma Krishnan | 14,435 | Open or private sale | $46.21 | $667,031.25 |
15th September 2020 | Suma Krishnan | 1,517 | Open or private sale | $47.15 | $71,523.21 |
29th June 2020 | Antony A Riley | 2,000 | Open or private purchase | $14.11 | $28,220.00 |
26th June 2020 | Antony A Riley | 4,700 | Open or private purchase | $14.52 | $68,225.20 |
15th June 2020 | Suma Krishnan | 8,652 | Open or private sale | $42.24 | $365,426.74 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Krystal Biotech, Inc. engages in developing and commercializing treatment for patients suffering from dermatological diseases. It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform.